Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment
Clinical trial NCT04480827 · COMPLETED
Trial details
- NCT number
- NCT04480827
- Sponsor
- Galmed Research and Development, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-13
- Primary completion
- 2022-03-24
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.